About Cytogen Corporation

About company

Cytogen is a biopharmaceutical company that is focused on the development and building of pharmaceutical products for cancer patients. Cytogen markets QUADRAMET, PROSTASCINT, CAPHOSOL, and SOLTAMOX. It also develops CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. Cytogen was acquired by EUSA Pharma in May 2008. Cytogen was founded by Thomas J. McKearn in 1980. It is based in Princeton, New Jersey.